Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions

Pigment Cell Melanoma Res. 2013 Jan;26(1):144-6. doi: 10.1111/pcmr.12037. Epub 2012 Nov 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrylamides / pharmacology
  • Cell Death / drug effects
  • Cell Line, Tumor
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Melanoma / drug therapy
  • Melanoma / enzymology*
  • Melanoma / genetics
  • Melanoma / pathology*
  • Nicotinamide Phosphoribosyltransferase / antagonists & inhibitors
  • Nicotinamide Phosphoribosyltransferase / genetics
  • Nicotinamide Phosphoribosyltransferase / metabolism*
  • Piperidines / pharmacology
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / enzymology*
  • Skin Neoplasms / genetics
  • Skin Neoplasms / pathology*

Substances

  • Acrylamides
  • Enzyme Inhibitors
  • N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide
  • Piperidines
  • Nicotinamide Phosphoribosyltransferase